Cagrilintide

Product Description

Cagrilintide is a long-acting amylin receptor agonist, structurally modified to mimic the natural hormone amylin, which is co-secreted with insulin by pancreatic β-cells. It is studied extensively for its role in appetite regulation, gastric emptying, and weight reduction. By acting on the area postrema and other brain regions involved in satiety, Cagrilintide shows promise in obesity, metabolic syndrome, and diabetes-related research models.

Benefits (Based on Preclinical Research):

• Suppresses appetite and enhances satiety

• Slows gastric emptying, supporting longer fullness between meals

• Promotes weight loss and reduction in adiposity

• Improves glycemic control in synergy with GLP-1 agonists

• Reduces food reward signaling in hypothalamic pathways

Who Uses This:

Researchers in endocrinology, obesity, and metabolic disease studies use Cagrilintide to explore non-stimulant pathways for appetite and weight control.

Why Choose Cagrilintide:

• Engineered for extended half-life and stable dosing

• Supplied lyophilized and sterile for laboratory use

• Validated through HPLC and Mass Spectrometry

• Provided with full Certificate of Analysis

• Useful in combination studies with GLP-1 agonists like Semaglutide

Documentation and Quality:

Each unit is shipped in cold-chain packaging with full lab documentation, batch-specific COA, and purity reports. Prepared under sterile lab conditions for research consistency.

Disclaimer:

Cagrilintide is intended for research use only. Not for human consumption, therapeutic, or diagnostic use. To be handled exclusively by licensed researchers in certified laboratories.